Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


ACC 2024: Adding investigative lerodalcibep to cholesterol lowering treatment shows significant efficacy

Written by | 18 Apr 2024

By adding investigational lerodalcibep to their standard cholesterol-lowering treatment for a year, patients at high risk for a heart attack or stroke achieved a reduction of “bad” cholesterol… read more.

Expanding pharmacists’ role for patients with hypertension could prevent 15 million heart attacks and save $1.1 trillion over 30 years, VCU-led study finds

Written by | 7 Nov 2023

If pharmacists had a larger role in prescribing medications to control blood pressure, they could prevent more than 15 million heart attacks, nearly 8 million strokes and more… read more.

Deadly heart attacks more common on a Monday

Written by | 26 Jun 2023

Serious heart attacks are more likely to happen at the start of the working week than at any other time, according to Irish data presented at the British… read more.

New troponin test improves heart attack diagnostics

Written by | 3 Nov 2022

A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency…. read more.

Global study: Risk of cardiovascular disease is similar for men and women

Written by | 27 Oct 2022

Findings from a global study suggest that risk factors for cardiovascular disease are similar for men and women, with some notable differences. The outcomes were reported on Oct…. read more.

Care gap: Hospital readmission rate for younger women is higher than for younger men after a heart attack

Written by | 7 Oct 2022

In a new study of younger heart attack victims in Ontario, Canada, researchers found that the healthcare system delivers high quality care for younger heart attack survivors; however, there are… read more.

“Polypill” reduces cardiovascular mortality by 33% in patients treated after a heart attack

Written by | 27 Aug 2022

A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in… read more.

Dietary salt substitutes lower risk of heart attack/stroke and death

Written by | 21 Aug 2022

Dietary salt substitutes lower the risk of heart attack, stroke, and death from all causes and cardiovascular disease, finds a pooled data analysis of the available evidence, published… read more.

Smartphone app calculates genetic risk for heart attack

Written by | 18 Mar 2022

A Scripps Research team developed a smartphone app that can calculate users’ genetic risk for coronary artery disease (CAD) — and found that users at high risk sought… read more.

Chest pain may extend outside the chest, often needs to be checked by a professional

Written by | 7 Nov 2021

Chest discomfort associated with a heart attack or heart event may often be felt beyond the chest, with many people reporting pain in their shoulders, arms, jaw, neck, back and… read more.

Can gastrointestinal bleeding after heart attack be predicted?

Written by | 6 Sep 2021

Knowing which patients are at higher risk of bleeding complications following a heart attack can help health professionals to take preventative measures. Now researchers at Karolinska have published… read more.

Target protein identified for improving heart attack treatment

Written by | 22 Jun 2021

A new study led by researchers at Washington State University has identified a protein that could be the key to improving treatment outcomes after a heart attack. Published… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.